Analgesia

Our products in this area
  • BuTrans® patches (7-day buprenorphine patches)
    SPC, PIL
  • DHC® Continus® tablets (prolonged release dihydrocodeine tartrate)
    SPC, PIL
  • MST® Continus® tablets (prolonged release morphine sulphate)
    SPC, PIL
  • MST® Continus® suspension (prolonged release morphine sulphate)
    SPC, PIL
  • MXL® capsules (prolonged release morphine sulphate)
    SPC, PIL
  • OxyContin® tablets (prolonged release oxycodone hydrochloride)
    5mg, 10mg, 20mg, 40mg, 80mg SPC PIL
    15mg, 30mg, 60mg, 120mg SPC PIL
  • OxyNorm® capsules (immediate release oxycodone hydrochloride)
    SPC, PIL
  • OxyNorm® injection (oxycodone hydrochloride)
    10mg/ml SPC PIL
    50mg/ml SPC PIL
  • OxyNorm® oral liquid (immediate release oxycodone hydrochloride)
    SPC, PIL
  • OxyNorm® oral concentrate (immediate release oxycodone hydrochloride)
    SPC, PIL
  • Palladone® SR capsules (prolonged release hydromorphone hydrochloride)
    SPC, PIL
  • Palladone® capsules (immediate release hydromorphone hydrochloride)
    SPC, PIL
  • Remedeine® tablets and Remedeine® forte tablets (immediate release dihydrocodeine tartrate/paracetamol)
    SPC, PIL
    Please note that Napp no longer sell the Remedeine® range, but it is now available from Crescent Pharma Limited
  • Sevredol® tablets (immediate release morphine sulphate)
    SPC, PIL
  • Targinact® tablets (prolonged release oxycodone hydrochloride/naloxone hydrochloride dihydrate)
    SPC, PIL
  • Transtec® patches (twice-weekly buprenorphine patches)
    SPC, PIL
Click here to read more
Napp websites

We own and maintain the following websites:

Click here to read more
Napp sponsored websites

We sponsor the following website, which is owned and maintained by Cardiff University Medical School:

Click here to read more
Independently Associated Company sponsored websites

The following websites are sponsored by our independently associated companies. Pain STORY and Pain Europe are sources of information about the impact of pain on patients’ health and quality of life; Pain Europe and EPG Online provide information and resources relating to the treatment of pain.

Click here to read more
Independent resources

The following websites offer information and resources for health professionals and/or patients:

Click here to read more
Last updated: 23 May 2013

All side effects experienced by patients should be reported to the product licence holder.

To report side effects with any of Napp’s medicines, you should use the MHRA’s Yellow Card Reporting System, and telephone Napp directly 01223 424444 asking to speak to the Drug Safety department or email the Drug Safety team (DrugSafetyUK@napp.co.uk).

This area of the site is intended for UK health professionals only, including doctors, nurses, pharmacists, and anyone else who, in the course of their professional duties, may prescribe, apply or administer medicines. The information includes the summaries of product characteristics for our products and links to other websites that may be of interest.

I confirm I am a UK healthcare professional and would like to proceed to the product area of the Napp site

This area of the site is intended for UK residents only. In this area of the site, you will find information about Napp’s medicines and links to other websites that may be of interest. This information is not intended as a substitute for the advice of a qualified health professional. If you have concerns about your health or the treatment you are receiving, we would encourage you to speak to your GP, pharmacist or another health professional.

I confirm that I have read the above and I wish to proceed to the product pages

You are now leaving napp.co.uk. Napp does not accept any responsibility for the third party site. Please click "Continue to external link" if you wish to proceed.

Continue to external link

You are now leaving napp.co.uk. Napp does not accept any responsibility for the third party site. Please click "Continue to external link" if you wish to proceed.

Continue to external link

Please note you are now leaving napp.co.uk. The following site is owned, sponsored by or authored by one of our independently associated companies and Napp does not accept any responsibility for the third party site. Please click "Continue to external link" if you wish to proceed.

Continue to external link